Strategic Partnerships & Investment Opportunities
Nura Health’s vision extends beyond diagnostics. We collaborate with academic institutions, global healthcare organizations, and commercial partners to develop accessible, AI-powered solutions that address a broad spectrum of women’s health issues—from endometriosis to prenatal genetic testing.
Our success is backed by notable endorsements, including a White House initiative led by First Lady Jill Biden, which awarded Nura Health a $3 million ARPA-H grant to commercialize an endometriosis care tool. We are also proud to partner with leading fertility clinics, OB/GYN practices, and telehealth platforms across the United States to accelerate our go-to-market strategy.
Investment Options
Interested in empowering women’s healthcare with AI and precision medicine? Nura Health is currently raising a $3M seed round to match federal grant funds and expedite product launches. For investor inquiries or partnership opportunities, contact us at invest@getnura.com.
Partnership Highlights
-
Federal Award: Selected as 1 of 23 awardees among 1700+ proposals for the ARPA-H Sprint for Women’s Health.
-
Clinical Collaborations: Working alongside world-renowned institutions and experts in reproductive endocrinology, minimally invasive gynecology, and precision medicine.
-
Commercial Laboratory Integration: Through IHDLab (FDA & CLIA-accredited), we can rapidly scale test availability to 80%+ of women’s health clinics on the West Coast.
-
Value-Based Contracting: We engage with Medicaid, Medi-Cal, employer health networks, and global payers to expand affordability and coverage for our tests.